2020 US Tumor Marker Testing Market: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

May 2020 | 620 pages | ID: 2198303E17F1EN
Venture Planning Group

Abstracts

Highlights

• Comprehensive 620-page analysis of the US tumor marker testing market.
• Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
• Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
• Five-year test volume and sales forecasts over for 40 tumor marker performed in US hospitals, commercial laboratories and physician offices.
• Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
• Current instrumentation technologies and feature comparison of leading analyzers.
• Sales and market shares of leading suppliers.
• Emerging diagnostic technologies and their potential market applications.
• Product development opportunities.
• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for suppliers.

Contains 620 pages and 103 tables

Contents

I. INTRODUCTION

II. MARKET OVERVIEW

A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

VII. MARKET AND TECHNOLOGY OVERVIEW

A. Major Current and Emerging Cancer Diagnostic Tests
  1. Biochemical Tumor Markers
  2. Oncogenes
  3. Polypeptide Growth Factors
  4. Ectopic Hormones
  5. Colony Stimulating Factors
  6. Lymphokines
  7. Immunohistochemical Stains
  8. Emerging Tumor Markers
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing

VIII. COUNTRY ANALYSIS

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Test and Market Segment
  Sales Forecasts by Test and Market Segment
  Major Supplier Sales and Market Shares

IX. COMPETITIVE PROFILES

Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
CellSearch
Cepheid
Clinical Genomics
Decode Genetics
DiaSorin
Diazyme
Eiken Chemical
Elitech Group
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic
Janssen Diagnostics
Kyowa Medex
Leica Biosystems
Myriad Genetics
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
PerkinElmer
Polymedco
Qiagen
Quest Diagnostics
Roche
Scienion
Sequenom
Siemens Healthineers
Takara Bio
Theradiag
Thermo Fisher
Tosoh
Vermillion
Wako Pure Chemicals

X. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS